Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,766 |
|
|||||
| News | - | ||||||
| Day High | 21.00 | Low High |
|||||
| Day Low | 20.74 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Synchronoss Technologies Inc | SNCRL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.20 | -0.94% | 20.9999 | 15:13:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 21.00 | 20.74 | 21.00 | 21.1999 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 18 | 1,766 | $ 20.93 | $ 36,955 | - | 16.40 - 22.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:13:49 | 10 | $ 20.67 | USD |
Synchronoss Technologies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 22.79M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Synchronoss Technologies News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNCRL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 20.55 | 21.1999 | 20.55 | 20.90 | 3,298 | 0.4499 | 2.19% |
| 1 Month | 21.25 | 21.28 | 17.55 | 20.92 | 6,680 | -0.2501 | -1.18% |
| 3 Months | 19.75 | 22.60 | 17.55 | 20.94 | 6,466 | 1.25 | 6.33% |
| 6 Months | 17.66 | 22.60 | 16.40 | 19.37 | 13,286 | 3.34 | 18.91% |
| 1 Year | 18.10 | 22.60 | 16.40 | 19.07 | 9,131 | 2.90 | 16.02% |
| 3 Years | 24.95 | 25.45 | 15.00 | 22.43 | 12,496 | -3.95 | -15.83% |
| 5 Years | 24.95 | 25.45 | 15.00 | 22.43 | 12,496 | -3.95 | -15.83% |
Synchronoss Technologies Description
| Synaptogenix, Inc. is a biopharmaceutical company. The Company is principally focused on developing therapeutics for patients with neurodegenerative diseases and developmental disorders. The Company is focused on developing a product platform based on a drug candidate called Bryostatin-1, which is synthesized from a natural product (bryostatin) that is isolated from a marine invertebrate organism, for the treatment of Alzheimer's disease (AD). Bryostatin-1 is a Protein Kinase C Epsilon (PKC e), a and e activator that was originally developed as a potential anticancer drug. The Company is evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease. |
